Sustained Effectiveness or Inevitable Discontinuation? Five-Year Real-World Outcomes of Teriflunomide Therapy in Multiple Sclerosis

Ozakbas S., Alızada S., Samadzade U., Caliskan C.

Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Barcelona, Spain, 24 - 26 September 2025, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Barcelona
• Country: Spain
• Dokuz Eylül University Affiliated: Yes